Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aakaar Medical Technologies's Other Operating Expense for the
six
months ended in Mar. 2026 was ₹140.3 Mil.
Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was ₹281.9 Mil.
Aakaar Medical Technologies's quarterly Other Operating Expense
increased
from Mar. 2025 (₹122.2 Mil) to Sep. 2025 (₹141.6 Mil) but then
declined
from Sep. 2025 (₹141.6 Mil) to Mar. 2026 (₹140.3 Mil).
Aakaar Medical Technologies's annual Other Operating Expense
increased
from Mar. 2024 (₹161.7 Mil) to Mar. 2025 (₹208.0 Mil) and
increased
from Mar. 2025 (₹208.0 Mil) to Mar. 2026 (₹230.8 Mil).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aakaar Medical Technologies Other Operating Expense Chart
Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)
Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.
Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹281.9 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Other Operating Expense of ₹281.9 Mil mean?
Aakaar Medical Technologies (NSE:AAKAAR) has a Other Operating Expense of ₹281.9 Mil as of Mar. 2026. Other operating expenses that a company records on its income statement. View historical data on Aakaar Medical Technologies and its competitors.
Is Aakaar Medical Technologies' Other Operating Expense too high?
Aakaar Medical Technologies' current Other Operating Expense is ₹281.9 Mil. Overall, Aakaar Medical Technologies has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Aakaar Medical Technologies' Other Operating Expense compare to ABT and SYK?
Aakaar Medical Technologies' Other Operating Expense of ₹281.9 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Medical Devices & Instruments company?
A good Other Operating Expense depends on the Medical Devices & Instruments industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Aakaar Medical Technologies and its competitors. Aakaar Medical Technologies's current Other Operating Expense is ₹281.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aakaar Medical Technologies stock overvalued right now?
Aakaar Medical Technologies (NSE:AAKAAR) has a current Other Operating Expense of ₹281.9 Mil. The current Other Operating Expense is ₹281.9 Mil. Aakaar Medical Technologies' overall GF Score™ is 21/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Aakaar Medical Technologies (NSE:AAKAAR), the current Other Operating Expense is ₹281.9 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Aakaar Medical Technologies Ltd is a medical aesthetic company dealing in a wide range of aesthetics & specialized cosmetic products & devices. Its product range includes both Own brands (domestically manufactured products & internationally manufactured devices) and Imported Brands (distribution of imported brands) from countries such as Korea, Spain, Italy, and Austria. It has established a distinctive presence in the medical aesthetic market by exclusively focusing on business-to-business(B2B) channels for product distribution and sales. The company supply its products & devices to dermatologists, plastic surgeons, aesthetic physicians who then sell these products to their end consumers as well as use certain device consumables as part of their treatments.
21GF Score
Get the complete analysis for NSE:AAKAAR
Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:AAKAAR has been successfully added to your 
